Floatz logo

Ethiodized Oil

Immune Checkpoint Blockade

Xinrui Zhu，MDPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Immune Checkpoint Blockade cohort.

Asset / SponsorPhaseRating
Adbelimumab
Fujian Cancer Hospital
Phase 2CCC
Rivoceranib
Fujian Cancer Hospital
Phase 2CCC
LENVATINIB
Xinrui Zhu，MD
Phase 1/2CCC
Theprubicin
Xinrui Zhu，MD
Phase 1/2CCC

Same molecule, other indications

Ethiodized Oil is also rated in:

hepatocellular carcinomaDormant
BB
Indicative ·
70 / 100
View asset →
Colon Cancer Liver MetastasisDormant
BB
Indicative ·
66 / 100
View asset →
Neoplastic Cells, CirculatingDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →